Rocket Lab USA is trading 4.7% down at $70.00, with no new company-specific announcement or clearly reported catalyst for September 30.
- Recent coverage points to investor concern about dilution and financing tied to the proposed Iridium acquisition, but reporting does not establish these as the direct cause of the decline.
- Supplied market indices are modestly higher, so broad-market weakness does not explain the move.